Atlas Trials

Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer

Clinical trial NCT05244434 · WITHDRAWN

Trial details

NCT number
NCT05244434
Sponsor
City of Hope Medical Center
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Advanced Breast AdenocarcinomaAdvanced HER2-Negative Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Hormone Receptor-Positive Breast CarcinomaMetastatic Breast AdenocarcinomaMetastatic HER2-Negative Breast CarcinomaPrognostic Stage III Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8
Start date
2022-07-03
Primary completion
2023-01-26
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.